©The Author(s) 2015.
World J Gastrointest Endosc. Apr 16, 2015; 7(4): 295-307
Published online Apr 16, 2015. doi: 10.4253/wjge.v7.i4.295
Published online Apr 16, 2015. doi: 10.4253/wjge.v7.i4.295
Table 1 Clinico-epidemiologic characteristics of Dieulafoy lesion
| Anatomy |
| Dilated, aberrant, submucosal artery eroding overlying gastrointestinal mucosa in absence of either underlying ulcer or local aneurysm |
| Location |
| 70% of ulcers in stomach |
| In stomach most commonly located within 6 cm of gastroesophageal junction along lesser curve |
| Can occur moderately commonly in esophagus or duodenum, occasionally in jejunum or ileum, and rarely in colon |
| Epidemiology |
| Generally presents clinically in older age, but can occur at any age |
| Male:female ratio = 2:1 |
| No known epidemiologic risk factors or clinically associated diseases |
| Clinical presentation |
| Typically presents with overt GI bleeding, often with hematemesis or melena, or both |
| Bleeding typically severe |
| No prodromal symptoms |
| Typically bleeding is painless |
| Frequent presentation with signs or laboratory tests of hemodynamic instability, including: tachycardia, hypotension, orthostasis, and acute prerenal azotemia |
| Frequently requires transfusion of multiple units of packed erythrocytes |
| Frequent recurrent bleeding if undetected or not treated at initial endoscopy |
- Citation: Nojkov B, Cappell MS. Gastrointestinal bleeding from Dieulafoy’s lesion: Clinical presentation, endoscopic findings, and endoscopic therapy. World J Gastrointest Endosc 2015; 7(4): 295-307
- URL: https://www.wjgnet.com/1948-5190/full/v7/i4/295.htm
- DOI: https://dx.doi.org/10.4253/wjge.v7.i4.295